Mycophenolate mofetil 200mg/mL; pwd for oral susp after reconstitution; mixed fruit flavor; contains phenylalanine. Store dry powder at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) ...

TORONTO, June 4 /PRNewswire/ -- The 12-month results from a multicenter trial monitoring CellCept(R) (mycophenolate mofetil) in combination with calcineurin inhibitors (CNIs) in renal transplantation ...

Discover comprehensive details about Mycophenolate Mofetil, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

♦Contraindicated to pregnant women and patients with known hypersensitivity. It should not be co-administered with Proton Pump Inhibitors (PPIs).

Embryo-fetal toxicity; rule out pregnancy with serum or urine pregnancy test immediately before starting therapy, then another test 8–10 days later. Repeat pregnancy tests during routine follow-up ...

Seattle, May 25 – Monitoring the level of CellCept® (mycophenolate mofetil) in a patient's blood in the months following an organ transplant may enable physicians to identify the precise amount of ...

CellCept (mycophenolate mofetil) is a prescription drug used to prevent organ rejection after certain organ transplants. CellCept’s cost may depend on factors such as your dosage, whether you have ...

Please provide your email address to receive an email when new articles are posted on . After 10 years of follow-up, CellCept was not shown to be superior to azathioprine for the treatment of lupus ...